DARBOMED Trademark

Trademark Overview

On Wednesday, March 2, 2016, a trademark application was filed for DARBOMED with the United States Patent and Trademark Office. The USPTO has given the DARBOMED trademark a serial number of 79185916. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, September 22, 2023. This trademark is owned by MEDICE Arzneimittel GmbH. The DARBOMED trademark is filed in the Pharmaceutical Products category with the following description:

Medical preparations for the treatment of anemia; Medicines for human purposes, namely, medicines for internal disorders and for the treatment of anemia
darbomed

General Information

Serial Number79185916
Word MarkDARBOMED
Filing DateWednesday, March 2, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, September 22, 2023
Registration Number5153242
Registration DateTuesday, March 7, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 20, 2016

Trademark Statements

Goods and ServicesMedical preparations for the treatment of anemia; Medicines for human purposes, namely, medicines for internal disorders and for the treatment of anemia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 22, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMEDICE Arzneimittel GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAT
Party NameMEDICE Arzneimittel GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAT
Party NameMEDICE Arzneimittel GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAT

Trademark Events

Event DateEvent Description
Tuesday, April 19, 2016APPLICATION FILING RECEIPT MAILED
Thursday, April 14, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, April 15, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 6, 2016ASSIGNED TO LIE
Wednesday, October 19, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 15, 2016ASSIGNED TO EXAMINER
Wednesday, June 22, 2016NON-FINAL ACTION WRITTEN
Thursday, June 23, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, June 27, 2016REFUSAL PROCESSED BY MPU
Monday, June 27, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, July 16, 2016REFUSAL PROCESSED BY IB
Wednesday, September 28, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 19, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 3, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 14, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 30, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 30, 2016NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 30, 2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, December 20, 2016PUBLISHED FOR OPPOSITION
Tuesday, December 20, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 7, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, June 7, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 20, 2017FINAL DISPOSITION PROCESSED
Saturday, December 17, 2016NOTIFICATION PROCESSED BY IB
Tuesday, June 20, 2017FINAL DISPOSITION NOTICE SENT TO IB
Saturday, July 8, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, March 7, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, September 22, 2023CANCELLED SECTION 71
Friday, June 14, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Tuesday, June 25, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sunday, July 14, 2024TOTAL INVALIDATION PROCESSED BY THE IB
Tuesday, June 25, 2024INVALIDATION PROCESSED

Related Keywords

darbomed anemia treatment medicines internal disorders namely purposes medical human preparations